Global Gastrointestinal Diseases Therapeutics Market 2022-2026

消化器疾患治療薬のグローバル市場2022-2026:抗炎症剤&免疫抑制剤、酸中和剤、その他

◆タイトル:Global Gastrointestinal Diseases Therapeutics Market 2022-2026
◆商品コード:IRTNTR43343-22
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2022年9月15日
◆ページ数:約120
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア、その他地域
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥0見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥0見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

Technavio社の本調査資料によると、世界の消化器疾患治療薬市場規模は2022年から2026年まで年平均6.68%成長し、16.0億ドルに達する見通しです。本書では、消化器疾患治療薬の世界市場を調査対象とし、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、薬剤分類別(抗炎症剤&免疫抑制剤、酸中和剤、その他)分析、顧客状況、地域別状況(北米、ヨーロッパ、アジア、アメリカ、日本、中国、ドイツ、フランス)分析、推進要因・課題・動向、企業状況、企業分析など、多面的な分析結果をまとめています。なお、本書には、主要企業として Abbott Laboratories、AbbVie Inc.、AstraZeneca Plc、Bausch Health Co Inc、Bayer AG、Biogen Inc.、Boston Scientific Corp.、C. H. Boehringer Sohn AG and Co. KG、Eisai Co. Ltd.、Eli Lilly and Co.などの企業情報が含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・世界の消化器疾患治療薬市場規模:薬剤分類別
- 消化器疾患用抗炎症剤&免疫抑制剤の市場規模2021 - 2026
- 消化器疾患用酸中和剤の市場規模2021 - 2026
- その他消化器疾患治療薬の市場規模2021 - 2026
・顧客状況
・地域別状況
- 北米の消化器疾患治療薬市場規模2021 - 2026
- ヨーロッパの消化器疾患治療薬市場規模2021 - 2026
- アジアの消化器疾患治療薬市場規模2021 - 2026
- アメリカの消化器疾患治療薬市場規模2021 - 2026
- 日本の消化器疾患治療薬市場規模2021 - 2026
- 中国の消化器疾患治療薬市場規模2021 - 2026
- ドイツの消化器疾患治療薬市場規模2021 - 2026
- フランスの消化器疾患治療薬市場規模2021 - 2026
・推進要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益、価格、競争、プロモーションなどの主要なパラメーターを分析することにより、また複数のソースからのデータを調査、統合、および合計することにより、市場の詳細な全体像を提示します。主要産業のインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは包括的​​で信頼性が高く、一次および二次の広範な調査の結果です。Technavio社の市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用し、完全な競争状況と詳細なベンダー選択方法と分析を提供します。

Global Gastrointestinal Diseases Therapeutics Market 2022-2026

Technavio has been monitoring the gastrointestinal diseases therapeutics market and it is poised to grow by $ 1.60 bn during 2022-2026, accelerating at a CAGR of 6.68% during the forecast period. Our report on the gastrointestinal diseases therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of gastrointestinal diseases, new product launches, and increasing demand for biologics and targeted therapies.

The gastrointestinal diseases therapeutics market analysis includes the product segment and geographic landscape.
Technavio’s gastrointestinal diseases therapeutics market is segmented as below:

By Product
• Anti-inflammatory and immunosuppressors
• Acid neutralizers
• Other therapeutics

By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the strong product pipeline as one of the prime reasons driving the gastrointestinal diseases therapeutics market growth during the next few years. Also, funding for gastrointestinal research studies and increase in self-medication coupled with home-based therapies will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the gastrointestinal diseases therapeutics market covers the following areas:
• Gastrointestinal diseases therapeutics market sizing
• Gastrointestinal diseases therapeutics market forecast
• Gastrointestinal diseases therapeutics market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gastrointestinal diseases therapeutics market vendors that include Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, Bausch Health Co Inc, Bayer AG, Biogen Inc., Boston Scientific Corp., C. H. Boehringer Sohn AG and Co. KG, Eisai Co. Ltd., Eli Lilly and Co., Evoke Pharma Inc, GlaxoSmithKline Plc, Johnson and Johnson, Merck and Co. Inc., Novartis AG, Olympus Corp., OVESCO ENDOSCOPY AG, Pfizer Inc., Takeda Pharmaceutical Co. Ltd., and UCB SA. Also, the gastrointestinal diseases therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

【資料の目次】

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Drug Class
o Exhibit 06: Executive Summary – Chart on Incremental Growth
o Exhibit 07: Executive Summary – Data Table on Incremental Growth
o Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis – Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition – Five forces 2021 and 2026
• 5 Market Segmentation by Drug Class
o 5.1 Market segments
o Exhibit 24: Chart on Drug Class – Market share 2021-2026 (%)
o Exhibit 25: Data Table on Drug Class – Market share 2021-2026 (%)
o 5.2 Comparison by Drug Class
o Exhibit 26: Chart on Comparison by Drug Class
o Exhibit 27: Data Table on Comparison by Drug Class
o 5.3 Anti-inflammatory and immunosuppressors – Market size and forecast 2021-2026
o Exhibit 28: Chart on Anti-inflammatory and immunosuppressors – Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Anti-inflammatory and immunosuppressors – Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Anti-inflammatory and immunosuppressors – Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Anti-inflammatory and immunosuppressors – Year-over-year growth 2021-2026 (%)
o 5.4 Acid neutralizers – Market size and forecast 2021-2026
o Exhibit 32: Chart on Acid neutralizers – Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Acid neutralizers – Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Acid neutralizers – Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Acid neutralizers – Year-over-year growth 2021-2026 (%)
o 5.5 Other therapeutics – Market size and forecast 2021-2026
o Exhibit 36: Chart on Other therapeutics – Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Other therapeutics – Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Other therapeutics – Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Other therapeutics – Year-over-year growth 2021-2026 (%)
o 5.6 Market opportunity by Drug Class
o Exhibit 40: Market opportunity by Drug Class ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 44: Chart on Geographic comparison
o Exhibit 45: Data Table on Geographic comparison
o 7.3 North America – Market size and forecast 2021-2026
o Exhibit 46: Chart on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on North America – Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on North America – Year-over-year growth 2021-2026 (%)
o 7.4 Europe – Market size and forecast 2021-2026
o Exhibit 50: Chart on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Europe – Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Europe – Year-over-year growth 2021-2026 (%)
o 7.5 Asia – Market size and forecast 2021-2026
o Exhibit 54: Chart on Asia – Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Asia – Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Asia – Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) – Market size and forecast 2021-2026
o Exhibit 58: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o 7.7 US – Market size and forecast 2021-2026
o Exhibit 62: Chart on US – Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on US – Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on US – Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on US – Year-over-year growth 2021-2026 (%)
o 7.8 Japan – Market size and forecast 2021-2026
o Exhibit 66: Chart on Japan – Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Japan – Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Japan – Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Japan – Year-over-year growth 2021-2026 (%)
o 7.9 China – Market size and forecast 2021-2026
o Exhibit 70: Chart on China – Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on China – Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on China – Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on China – Year-over-year growth 2021-2026 (%)
o 7.10 Germany – Market size and forecast 2021-2026
o Exhibit 74: Chart on Germany – Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Germany – Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Germany – Year-over-year growth 2021-2026 (%)
o 7.11 France – Market size and forecast 2021-2026
o Exhibit 78: Chart on France – Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on France – Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on France – Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on France – Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 82: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 Abbott Laboratories
o Exhibit 89: Abbott Laboratories – Overview
o Exhibit 90: Abbott Laboratories – Business segments
o Exhibit 91: Abbott Laboratories – Key news
o Exhibit 92: Abbott Laboratories – Key offerings
o Exhibit 93: Abbott Laboratories – Segment focus
o 10.4 AbbVie Inc.
o Exhibit 94: AbbVie Inc. – Overview
o Exhibit 95: AbbVie Inc. – Product / Service
o Exhibit 96: AbbVie Inc. – Key offerings
o 10.5 AstraZeneca Plc
o Exhibit 97: AstraZeneca Plc – Overview
o Exhibit 98: AstraZeneca Plc – Product / Service
o Exhibit 99: AstraZeneca Plc – Key news
o Exhibit 100: AstraZeneca Plc – Key offerings
o 10.6 Bausch Health Co Inc
o Exhibit 101: Bausch Health Co Inc – Overview
o Exhibit 102: Bausch Health Co Inc – Business segments
o Exhibit 103: Bausch Health Co Inc – Key news
o Exhibit 104: Bausch Health Co Inc – Key offerings
o Exhibit 105: Bausch Health Co Inc – Segment focus
o 10.7 C. H. Boehringer Sohn AG and Co. KG
o Exhibit 106: C. H. Boehringer Sohn AG and Co. KG – Overview
o Exhibit 107: C. H. Boehringer Sohn AG and Co. KG – Business segments
o Exhibit 108: C. H. Boehringer Sohn AG and Co. KG – Key news
o Exhibit 109: C. H. Boehringer Sohn AG and Co. KG – Key offerings
o Exhibit 110: C. H. Boehringer Sohn AG and Co. KG – Segment focus
o 10.8 GlaxoSmithKline Plc
o Exhibit 111: GlaxoSmithKline Plc – Overview
o Exhibit 112: GlaxoSmithKline Plc – Business segments
o Exhibit 113: GlaxoSmithKline Plc – Key news
o Exhibit 114: GlaxoSmithKline Plc – Key offerings
o Exhibit 115: GlaxoSmithKline Plc – Segment focus
o 10.9 Johnson and Johnson
o Exhibit 116: Johnson and Johnson – Overview
o Exhibit 117: Johnson and Johnson – Business segments
o Exhibit 118: Johnson and Johnson – Key news
o Exhibit 119: Johnson and Johnson – Key offerings
o Exhibit 120: Johnson and Johnson – Segment focus
o 10.10 Merck and Co. Inc.
o Exhibit 121: Merck and Co. Inc. – Overview
o Exhibit 122: Merck and Co. Inc. – Business segments
o Exhibit 123: Merck and Co. Inc. – Key news
o Exhibit 124: Merck and Co. Inc. – Key offerings
o Exhibit 125: Merck and Co. Inc. – Segment focus
o 10.11 Takeda Pharmaceutical Co. Ltd.
o Exhibit 126: Takeda Pharmaceutical Co. Ltd. – Overview
o Exhibit 127: Takeda Pharmaceutical Co. Ltd. – Product / Service
o Exhibit 128: Takeda Pharmaceutical Co. Ltd. – Key news
o Exhibit 129: Takeda Pharmaceutical Co. Ltd. – Key offerings
o 10.12 UCB SA
o Exhibit 130: UCB SA – Overview
o Exhibit 131: UCB SA – Product / Service
o Exhibit 132: UCB SA – Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 133: Inclusions checklist
o Exhibit 134: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 135: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 136: Research methodology
o Exhibit 137: Validation techniques employed for market sizing
o Exhibit 138: Information sources
o 11.5 List of abbreviations
o Exhibit 139: List of abbreviations
o disease

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Drug Class
Exhibits6: Executive Summary – Chart on Incremental Growth
Exhibits7: Executive Summary – Data Table on Incremental Growth
Exhibits8: Executive Summary – Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global – Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis – Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants – Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes – Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry – Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition – Five forces 2021 and 2026
Exhibits24: Chart on Drug Class – Market share 2021-2026 (%)
Exhibits25: Data Table on Drug Class – Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Drug Class
Exhibits27: Data Table on Comparison by Drug Class
Exhibits28: Chart on Anti-inflammatory and immunosuppressors – Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Anti-inflammatory and immunosuppressors – Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Anti-inflammatory and immunosuppressors – Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Anti-inflammatory and immunosuppressors – Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Acid neutralizers – Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Acid neutralizers – Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Acid neutralizers – Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Acid neutralizers – Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Other therapeutics – Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Other therapeutics – Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Other therapeutics – Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Other therapeutics – Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Drug Class ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America – Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America – Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America – Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America – Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe – Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe – Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe – Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia – Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia – Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia – Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US – Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US – Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US – Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US – Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Japan – Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Japan – Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Japan – Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Japan – Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China – Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China – Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China – Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China – Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Germany – Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Germany – Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Germany – Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on France – Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on France – Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on France – Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on France – Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: Abbott Laboratories – Overview
Exhibits90: Abbott Laboratories – Business segments
Exhibits91: Abbott Laboratories – Key news
Exhibits92: Abbott Laboratories – Key offerings
Exhibits93: Abbott Laboratories – Segment focus
Exhibits94: AbbVie Inc. – Overview
Exhibits95: AbbVie Inc. – Product / Service
Exhibits96: AbbVie Inc. – Key offerings
Exhibits97: AstraZeneca Plc – Overview
Exhibits98: AstraZeneca Plc – Product / Service
Exhibits99: AstraZeneca Plc – Key news
Exhibits100: AstraZeneca Plc – Key offerings
Exhibits101: Bausch Health Co Inc – Overview
Exhibits102: Bausch Health Co Inc – Business segments
Exhibits103: Bausch Health Co Inc – Key news
Exhibits104: Bausch Health Co Inc – Key offerings
Exhibits105: Bausch Health Co Inc – Segment focus
Exhibits106: C. H. Boehringer Sohn AG and Co. KG – Overview
Exhibits107: C. H. Boehringer Sohn AG and Co. KG – Business segments
Exhibits108: C. H. Boehringer Sohn AG and Co. KG – Key news
Exhibits109: C. H. Boehringer Sohn AG and Co. KG – Key offerings
Exhibits110: C. H. Boehringer Sohn AG and Co. KG – Segment focus
Exhibits111: GlaxoSmithKline Plc – Overview
Exhibits112: GlaxoSmithKline Plc – Business segments
Exhibits113: GlaxoSmithKline Plc – Key news
Exhibits114: GlaxoSmithKline Plc – Key offerings
Exhibits115: GlaxoSmithKline Plc – Segment focus
Exhibits116: Johnson and Johnson – Overview
Exhibits117: Johnson and Johnson – Business segments
Exhibits118: Johnson and Johnson – Key news
Exhibits119: Johnson and Johnson – Key offerings
Exhibits120: Johnson and Johnson – Segment focus
Exhibits121: Merck and Co. Inc. – Overview
Exhibits122: Merck and Co. Inc. – Business segments
Exhibits123: Merck and Co. Inc. – Key news
Exhibits124: Merck and Co. Inc. – Key offerings
Exhibits125: Merck and Co. Inc. – Segment focus
Exhibits126: Takeda Pharmaceutical Co. Ltd. – Overview
Exhibits127: Takeda Pharmaceutical Co. Ltd. – Product / Service
Exhibits128: Takeda Pharmaceutical Co. Ltd. – Key news
Exhibits129: Takeda Pharmaceutical Co. Ltd. – Key offerings
Exhibits130: UCB SA – Overview
Exhibits131: UCB SA – Product / Service
Exhibits132: UCB SA – Key offerings
Exhibits133: Inclusions checklist
Exhibits134: Exclusions checklist
Exhibits135: Currency conversion rates for US$
Exhibits136: Research methodology
Exhibits137: Validation techniques employed for market sizing
Exhibits138: Information sources
Exhibits139: List of abbreviations



★調査レポート[消化器疾患治療薬のグローバル市場2022-2026:抗炎症剤&免疫抑制剤、酸中和剤、その他] (Global Gastrointestinal Diseases Therapeutics Market 2022-2026 / IRTNTR43343-22)販売に関する免責事項
[消化器疾患治療薬のグローバル市場2022-2026:抗炎症剤&免疫抑制剤、酸中和剤、その他] (Global Gastrointestinal Diseases Therapeutics Market 2022-2026 / IRTNTR43343-22)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆